ReviewThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi2025
[Emerging Diagnostic Techniques and Therapies for Upper Gastrointestinal Bleeding].
Review in The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endoscopic Treatment of Upper Gastrointestinal Bleeding.The Korean journal of helicobacter and upper gastrointestinal research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The clinical outcomes of upper gastrointestinal bleeding (UGIB) have improved in recent years because of standardized peri-endoscopy care and advances in endoscopic procedures. Early identification of high-risk patients is essential for intensive management and pre-emptive intervention. Therefore, an accurate, rapid, easy-to-interpret, and non-invasive tool can assist in diagnosing and offering guidance for clinical decision-making in scenarios of a suspected UGIB. Although standard endoscopic treatment is indispensable, the emergence of novel endoscopic therapies has brought about significant advances in the landscape of UGIB management, yielding improved outcomes. Further research into these novel treatments is needed to understand their efficacy and safety profiles and enhance their role in the management of UGIB in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.